MetaCap

Jaguar Health (JAGX) vs Medicus Pharma (MDCX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Medicus Pharma is the larger company by market cap ($3.2 million vs $3.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

JAGX-95.46%MDCX+608.49%
+2246%+1020%-207%
Oct 7, 20261 yearNov 20, 2026
JAGX-95.26%MDCX+1132.36%
+3605%+1667%-271%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

JAGX versus MDCX key metrics
MetricJAGXMDCX
Share price$0.227$1.14
Market cap$3.03M$3.16M
1-day change-30.58%-2.16%
YTD return—-25.82%
1-year return—-46.71%
EPS (TTM)$-257.15$-76.65
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$11.51M—
Revenue growth (YoY)-1.52%—
Net income (latest FY)$-53.58M$-47.28M
Gross margin67.21%—
Operating margin-398.82%—
Net margin-465.42%—
52-week high$981.75$114.00
52-week low$0.22$1.06
Distance from 52-week high-99.98%-99.00%
Analyst consensus—none
Avg. price target upside—+296.48%
Average volume2.40M116.55K
Shares outstanding13.35M2.79M
Employees4716
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Jaguar Health

JAGX stock →

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health.

Health Care · Biotechnology: Pharmaceutical Preparations · 47 employees

About Medicus Pharma

MDCX stock →

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.

Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees

JAGX vs MDCX FAQ

Which is bigger, Jaguar Health or Medicus Pharma?

Medicus Pharma (MDCX) is larger, with a market capitalization of $3.16M compared with $3.03M for Jaguar Health (JAGX).

Are Jaguar Health and Medicus Pharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons